How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...

Historically, the presence of measurable disease has been considered essential to stimulate CAR T-cell expansion and persistence. However, the kinetics of CAR T cells in patients achieving complete ...

Evaxion AS (EVAX) reports a significant cash increase and positive vaccine data, despite facing macroeconomic challenges.

The mechanisms governing immune-related adverse events resulting from checkpoint inhibition therapy for cancer remain a ...

Strong Q1 2025 results for Evaxion (EVAX) with a boosted cash position, progress in oncology & infectious diseases, and key milestones ahead.

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are planne ...

Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity ...

The following is a summary of “Expansion of multiple CD4+ T cell lineages in lymphocytic variant hypereosinophilic syndrome,” ...

The research team demonstrated that innate immune cells called Natural Killer (NK) cells that express CD8a on the cell ...